Business
Result of Offer to Qualifying
Result of Offer to Qualifying.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n RNS Number : 7116U Allergy Therapeutics PLC 29 June 2009 \n \nMonday 29 June 2009\n\nAllergy Therapeutics plc\n(\"Allergy Therapeutics\" or \"the Company\")\n\nResult of Offer to Qualifying Participants \n\nAllergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, announced a fundraising that included an offer to qualifying shareholders and qualifying employees (\"Qualifying Participants\") of up to 17,835,233 new ordinary shares of 0.1p each of the Company at a price of 12p per share (the \"Offer\") on 12 June 2009.\n\nThe Company is pleased to announce that, at the close of the Offer, Qualifying Participants had applied for 12,915,375 new ordinary shares of 0.1p each at a price of 12p per share raising approximately £1.5 million.\n\nThe Offer was in addition to the placing and subscription, also announced on 12 June 2009, which conditionally raised £20.2 million (\"Placing and Subscription\").\n\nThe Offer, together with the Placing and Subscription, are subject to the approval of shareholders of the Company at a General Meeting to be held at 11.00 a.m. on Tuesday, 30 June 2009.\n\nIt is expected that dealings in the 181,631,937 ordinary shares of 0.1p each issued pursuant to the Offer and the Placing and Subscription will commence on AIM on 1 July 2009.\n\nDetails of the Offer, the Placing and Subscription were set out in the announcement published by the Company on 12 June 2009.\n\nFor further information\n\n\n\n\n\nAllergy Therapeutics\n\n\n+44 (0) 1903 845 820\n\n\n\n\nKeith Carter, Chief Executive\n\n\n\n\n\n\n\nwww.allergytherapeutics.com\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNomura Code Securities\n\n\n+44 (0) 207 776 1200\n\n\n\n\nJuliet Thompson/ Clare Terlouw\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFinancial Dynamics\n\n\n+44 (0) 207 831 3113\n\n\n\n\nBen Brewerton/ Susan Quigley\n\n\n\n\n\n\n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END ROICKCKNPBKDKAB\n ","length":4315,"tagName":"div"}]